3,5-di-O-acetyl-1-O-[(5beta,8alpha,9beta,10alpha)-18-oxokaur-16-en-18-yl]-beta-L-arabinofuranose

Term ID

CHEBI:65753

Synonyms

18-beta-L-3',5'-diacetoxy-arabinofuranosyl-ent-kaur-16-ene
3,5-di-O-acetyl-1-O-[(5beta,8alpha,9beta,10alpha)-18-oxokaur-16-en-18-yl]-beta-L-arabinofuranose

Definition

An ent-kaurane diterpenoid that is ent-kaur-16-en-18-oic acid substituted by a beta-L-3',5'-diacetoxy-arabinofuranosyl moiety at position 18 via a glycosidic linkage. It is isolated from the whole herb of Sagittaria pygmaea and exhibits antibacterial activity against the oral pathogens.

References

PMID:17315313

Ontology

ChEBI ( EBI )

Relationships

is a type of: acetate ester ent-kaurane diterpenoid

acetate ester ent-kaurane diterpenoid Show first 5 Terms
has_functional_parent: beta-L-arabinofuranose

beta-L-arabinofuranose Show first 5 Terms
has_role: antibacterial agent metabolite

antibacterial agent metabolite Show first 5 Terms

Phenotype

Phenotype resulting from 3,5-di-O-acetyl-1-O-[(5beta,8alpha,9beta,10alpha)-18-oxokaur-16-en-18-yl]-beta-L-arabinofuranose

Phenotype where environments contain 3,5-di-O-acetyl-1-O-[(5beta,8alpha,9beta,10alpha)-18-oxokaur-16-en-18-yl]-beta-L-arabinofuranose

Phenotype modified by environments containing 3,5-di-O-acetyl-1-O-[(5beta,8alpha,9beta,10alpha)-18-oxokaur-16-en-18-yl]-beta-L-arabinofuranose

Human Disease Model